Developments in Cancer Treatments, Market Dynamics, Patient Access and Value, IMS Institute, May 2015
A cluster of innovative medicines for patients with a wide variety of tumor types and based on promising new mechanisms of action has heightened excitement about prospects for major advances in cancer treatment. The large number of potential new medicines currently in clinical development or under regulatory review suggests breakthroughs will continue and bring not […]